Milene Moritz

Dr. Milene Moritz

University of Sao Paulo
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MMMilene Moritz
Milene Moritz
AMAlyssa Merkel
Alyssa Merkel
EFEan G. Feldman
Ean G. Feldman
HAHELOISA SOBREIRO SELISTRE DE ARAUJO
HELOISA SOBREIRO SELISTRE DE ARAUJO
Julie RhoadesJulie Rhoades
Julie Rhoades
Integrins participate in the pathogenesis and progression of tumors at many stages during the metastatic cascade. However, current evidence for the role of integrins in breast cancer progression is contradictory and seems to be dependent on tumor stage, differentiation status, and microenvironmental influences. While some studies suggest that loss of α2β1 enhances cancer metastasis, other studies suggest that this integrin is pro-tumorigenic. However, few studies have looked at α2β1 in the context of bone metastasis. In this study, we aimed to understand the role of α2β1 integrin in breast cancer metastasis to bone. To address this, we utilized in vivo models of breast cancer metastasis to bone using MDA-MB-231 cells transfected with an α2 expression plasmid (MDA-OEα2). MDA cells overexpressing the α2 integrin subunit had increased primary tumor growth and dissemination to bone but had no change in tumor establishment and bone destruction. Further in vitro analysis revealed that tumors in the bone have decreased α2β1 expression and increased osteolytic signaling compared to primary tumors. Taken together, these data suggest an inverse correlation between α2β1 expression and bone-metastatic potential. Inhibiting α2β1 expression may be beneficial to limit the expansion of primary tumors but could be harmful once tumors have established in bone.

8 February 2022 in Toxicon
Verified
Journal Article
Closed access
MMMilene Moritz
Milene Moritz
BCBruna Carla Casali
Bruna Carla Casali
USUliana Sbeguen Stotzer
Uliana Sbeguen Stotzer
PSPatty Karina dos Santos
Patty Karina dos Santos
HSHeloisa Sobreiro Selistre-De-Araujo
Heloisa Sobreiro Selistre-De-Araujo

1 March 2017 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
MMMilene Moritz
Milene Moritz
JGJoyce L.S. Gonçalves
Joyce L.S. Gonçalves
ILIrwin A.P. Linares
Irwin A.P. Linares
JPJanice R. Perussi
Janice R. Perussi
KOKleber De Oliveira
Kleber De Oliveira

1 September 2016 in Biochimie
Verified
Journal Article
Closed access
KMKelli Cristina Micocci
Kelli Cristina Micocci
MMMilene Moritz
Milene Moritz
RLRafael Luis Bressani Lino
Rafael Luis Bressani Lino
LFLaila Ribeiro Fernandes
Laila Ribeiro Fernandes
ALAntonio Gilclêr Ferreira Lima
Antonio Gilclêr Ferreira Lima
HAHELOISA SOBREIRO SELISTRE DE ARAUJO
HELOISA SOBREIRO SELISTRE DE ARAUJO

1 July 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Open access
AVAndrea Carolina Van de Velde
Andrea Carolina Van de Velde
CGClaudia Carolina Gay
Claudia Carolina Gay
MMMilene Moritz
Milene Moritz
PSPatty Karina dos Santos
Patty Karina dos Santos
Soledad BustilloSoledad Bustillo
Soledad Bustillo
LLLaura Cristina Leiva
Laura Cristina Leiva

25 April 2018 in Journal of Venomous Animals and Toxins including Tropical Diseases
Verified
Journal Article
Open access
PDF file
MMMilene Moritz
Milene Moritz
LELívia Mara Santos Eustáquio
Lívia Mara Santos Eustáquio
KMKelli Cristina Micocci
Kelli Cristina Micocci
Ana Carolina Caetano NunesAna Carolina Caetano Nunes
Ana Carolina Caetano Nunes
PSPatty Karina dos Santos
Patty Karina dos Santos
HAHELOISA SOBREIRO SELISTRE DE ARAUJO
HELOISA SOBREIRO SELISTRE DE ARAUJO
Matrix metalloproteinases (MMPs) are key players in tumor progression, helping tumor cells to modify their microenvironment, which allows cell migration to secondary sites. The role of integrins, adhesion receptors that connect cells to the extracellular matrix, in MMP expression and activity has been previously suggested. However, the mechanisms by which integrins control MMP expression are not completely understood. Particularly, the role of α2β1 integrin, one of the major collagen I receptors, in MMP activity and expression has not been studied. Alternagin-C (ALT-C), a glutamate-cysteine-aspartate-disintegrin from Bothrops alternatus venom, has high affinity for an α2β1 integrin. Herein, we used ALT-C as a α2β1 integrin ligand to study the effect of ALT-C on MMP-9 and MMP-2 expression as well as on tumor cells, fibroblats and endothelial cell migration. ALT-C was purified by two steps of gel filtration followed by anion exchange chromatography. The α2β1 integrin binding properties of ALT-C, its dissociation constant (K d ) relative to this integrin and to collagen I (Col I) were determined by surface plasmon resonance. The effects of ALT-C (10, 40, 100 and 1000 nM) in migration assays were studied using three human cell lines: human fibroblasts, breast tumor cell line MDA-MB-231, and microvascular endothelial cells HMEC-1, considering cells found in the tumor microenvironment. ALT-C effects on MMP-9 and MMP-2 expression and activity were analyzed by quantitative PCR and gelatin zymography, respectively. Focal adhesion kinase activation was determined by western blotting. Our data demonstrate that ALT-C, after binding to α2β1 integrin, acts by two distinct mechanisms against tumor progression, depending on the cell type: in tumor cells, ALT-C decreases MMP-9 and MMP-2 contents and activity, but increases focal adhesion kinase phosphorylation and transmigration; and in endothelial cells, ALT-C inhibits MMP-2, which is necessary for tumor angiogenesis. ALT-C also upregulates c-Myc mRNA level, which is related to tumor suppression. These results demonstrate that α2β1 integrin controls MMP expression and reveal this integrin as a target for the development of antiangiogenic and antimetastatic therapies.